We use cookies for a better user experience. Read our Privacy Policy

I Agree

Middle East Africa Direct-to-Consumer Laboratory Testing Market Outlook, 2021-2031

Direct-to-Consumer Laboratory Testing Market (Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Chronic Disease Testing, COVID-19 Testing, TSH Testing, and Others; Sample Type: Blood, Saliva, Urine, and Others; and Provider: Hospitals, Clinics, Specialty Labs, and Diagnostic Centers) - Middle East & Africa Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

COVID-19 Test Home Collection Kits Gain Popularity in Middle East and Africa

Since the U.S. Food and Drug Administration (FDA) authorized LabCorp’s Pixel COVID-19 Test Home Collection Kit, companies in the MEA direct-to-consumer laboratory testing market are taking cues from the same. Manufacturers are developing COVID-19 test home collection kits that can be used by individuals of 18 years and above without the need for a prescription. Such kits are allowing users to self-collect a nasal swab sample at home and then send that sample for testing to labs.

Companies in the MEA direct-to-consumer laboratory testing market are innovating in COVID-19 test home collection kits that enable positive or invalid results that are delivered to the user by phone call from a healthcare provider or a lab.

mea direct to consumer laboratory testing market infographic

Request a sample to get extensive insights into the Direct-to-Consumer Laboratory Testing Market

Lack of Regulations for Genetic DTC Testing Affects Market Growth

The MEA direct-to-consumer laboratory testing market is expected to expand at a CAGR of 18.3% during the forecast period. The cost of gene sequencing is decreasing due to advancements in next gen sequencing (NGS) and increasing availability of direct-to-consumer (DTC) laboratory testing. However, it has been found that in many cases, DTC tests are not regulated by the government healthcare organizations. Hence, healthcare companies and healthcare authorities should collaborate to implement regulations regarding DTC, and create awareness about the key differences and limitations between clinical & DTC genetic tests.

Manufacturers are increasing R&D in low cost and automated tests with automated analysis and reporting.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Companies Pursuing Opportunities in DTC Testing Due to Growth in Telehealth

The surge in the demand for DTC testing is part of a broader shift toward telehealth and eCommerce as a result of the ongoing coronavirus pandemic. Virtual care is likely to surge in the upcoming years, since weekly visits are growing at a substantial rate. Market stakeholders are setting their collaboration wheels in motion to sell new COVID-19 home sample collection kits.

Stakeholders in the MEA direct-to-consumer laboratory testing market are scaling up testing and telehealth services due to the ongoing pandemic. They have been working at break-neck speed to meet the unprecedented demand for COVID-19 home sample collection kits. Healthcare companies are expanding their marketing strategy spanning from podcosts to news channels to increase acceptance of DTC operations.

DTC Genetic Testing Enabling Access to Information on Risks of Cancer

Personalized, precision, and genomic medicines based on DNA sequencing hold potentials to offer opportunities for improving the overall public health. The MEA direct-to-consumer laboratory testing market is undergoing a significant change with DNA sequencing being applied for disease prevention such as heart diseases, cancers, and metabolic diseases.

The identification of patients’ risk profile is becoming necessary in the MEA direct-to-consumer laboratory testing market. This is explains why the market is anticipated to reach US$ 928.34 Mn by 2031. DTC genetic testing (DTCGT) is allowing access to information on their risks of suffering from a wide range of chronic diseases.

Patient-centered Patient Care Creating Revenue Opportunities for Stakeholders

Telehealth is making it possible for increasing the availability of direct-to-consumer laboratory testing. Patient-centered laboratory stewardship is acting as a key driver for the MEA direct-to-consumer laboratory testing market. There is a growing need for patient care that is respectful of and responsive to individual patient preferences, values, and needs. These trends are ensuring that patient values guide all clinical decisions.

The concept of patient centered capitalism is storming the MEA direct-to-consumer laboratory testing market. Stakeholders are prioritizing the interests of patients over those of financial and other stakeholders within both the healthcare system & its suppliers. Patient-centered laboratory stewardship is proving beneficial to improve important areas of lab testing and DTC testing such as test ordering, result retrieval, result interpretation, and financial fairness for patients and other stakeholders.

mea direct to consumer laboratory testing market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Direct-to-Consumer Laboratory Testing Market

Analysts’ Viewpoint

With the COVID-19 pandemic accelerating interest in telehealth and consumer-initiated testing, companies in the MEA direct-to-consumer laboratory testing market are aiming to expand their DTC operations. DTC genetic testing aimed at guiding a patient’s diet or exercise remains largely unproven in producing better outcomes. Hence, market stakeholders should collaborate and implement laboratory stewardship programs that put in safeguards to improve patient-centered care.

Genetic counseling sessions are being conducted to explain details and options at appropriate education levels. Mobile apps are being developed to facilitate patient retrieval of results. Healthcare providers in the MEA direct-to-consumer laboratory testing market are increasing patient access to their electronic medical records. Moreover, educational materials are being written in patient’s language of choice. Enhanced communication between patients and physicians through text, phone, and electronic medical record is helping to improve patient quality of life.

Middle East & Africa Direct-to-Consumer Laboratory Testing Market: Overview

  • This report analyzes the current scenario and future prospects of the direct-to-consumer laboratory testing market in MEA. Direct-to-consumer laboratory testing, also known as direct access testing, allows patients to order tests directly from a lab without having to go through a healthcare professional. These test results can be used to track current health condition, diagnose a previously undiagnosed medical condition, or provide information on personal health traits. In line with the rise in demand for quick, affordable, and accurate tests, several companies have considered offering actionable recommendations to complement the test results. This approach induces customers to seek personalized services and maximizes customer satisfaction.
  • The report includes an elaborate executive summary, which provides a snapshot of various segments and sub-segments of the direct-to-consumer laboratory testing market in MEA. It also provides information and data analysis of the direct-to-consumer laboratory testing market in MEA about segments based on test type, sample type, provider, and country/sub-region.
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the direct-to-consumer laboratory testing market in MEA
  • The report includes company profiles, which provide information about their business, product portfolios, strategic overview, and competitive landscape in the direct-to-consumer laboratory testing market in MEA
  • The report on the direct-to-consumer laboratory testing market in MEA offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the direct-to-consumer laboratory testing market in MEA. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the direct-to-consumer laboratory testing market in MEA.

Middle East & Africa Direct-to-Consumer Laboratory Testing Market: Key Segments

  • In terms of test type, the direct-to-consumer laboratory testing market in MEA has been classified into genetic testing, disease risk assessment testing, CBC, chronic disease testing, COVID-19 testing, TSH testing, and others. The genetic testing segment has been split into nutrigenetics test, celiac disease test, sports & physical activity testing, men's health tests, women's health tests, pregnancy & prenatal screening, general health testing, and others. The nutrigenetics test sub-segment has been segregated into weight control, lactose intolerance, and others. The disease risk assessment testing segment has been categorized into sexual health tests, cancer predisposition tests, and others. The sexual health tests sub-segment has been split into HIV, chlamydia, and others. The chronic disease testing segment has been segregated into diabetes testing, hypertension, and others.
  • Based on sample type, the direct-to-consumer laboratory testing market in MEA has been categorized into blood, saliva, urine, and others
  • In terms of provider, the direct-to-consumer laboratory testing market in MEA has been divided into hospitals, clinics, specialty labs, and diagnostic centers
  • Market size and forecast for each of these segments and sub-segments have been provided from 2017 to 2031. The CAGR of respective segment has also been provided from 2021 to 2031, considering 2020 as the base year, and 2017, 2018, and 2019 as historical years.

Middle East & Africa Direct-to-Consumer Laboratory Testing Market: Regional Outlook

  • In terms of country/sub-region, the direct-to-consumer laboratory testing market in MEA has been segmented into GCC Countries, South Africa, and Rest of MEA
  • The direct-to-consumer laboratory testing market report provides size and forecast for each sub-region from 2017 to 2031. The CAGR for each of these sub-regions has also been provided for the forecast period from 2021 to 2031. The direct-to-consumer laboratory testing market study covers the competitive scenario in these sub-regions.

Companies Covered in Middle East & Africa Direct-to-Consumer Laboratory Testing Market Report

  • Key players in the direct-to-consumer laboratory testing market in MEA have been profiled based on attributes such as company overview, product portfolio, financial overview, strategic overview, recent developments, and competitive business strategies
  • Major companies profiled in the direct-to-consumer laboratory testing market report are
    • 23andMe, Inc.
    • Ancestry
    • CircleDNA
    • Eurofins Scientific
    • Family Tree DNA (Gene by Gene)
    • Laboratory Corporation of America Holdings
    • Living DNA Ltd.
    • Medichecks.com Ltd.
    • MyHeritage Ltd.
    • MyMedLab, Inc.
    • Quest Diagnostics Incorporated

Middle East & Africa Direct-to-Consumer Laboratory Testing Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 124.40 Mn

Market Forecast Value in 2031

US$ 928.34 Mn

Growth Rate (CAGR)

18.3%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis at MEA as well as sub-region level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key industry events, etc.

Competition Landscape

Market share analysis by company (2020)

Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, key financials, etc.

Format

Electronic (PDF) + Excel

Market Segmentation

  • Test Type
  • Genetic Testing
    • Nutrigenetics Test
      • Weight Control
      • Lactose Intolerance
      • Others
    • Celiac Disease Test
    • Sports and Physical Activity Testing
    • Men's Health Tests
    • Women's Health Tests
    • Pregnancy and Prenatal Screening
    • General Health Testing
    • Others
  • Disease Risk Assessment Testing
    • Sexual Health Tests
      • HIV
      • Chlamydia
      • Others
    • Cancer Predisposition Tests
    • Others
  • CBC
  • Chronic Disease Testing
    • Diabetes Testing
    • Hypertension
    • Others
  • COVID-19 Testing
  • TSH Testing
  • Others
  • Sample Type
  • Blood
  • Saliva
  • Urine
  • Others
  • Provider
  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centers

Regions Covered

MEA

 

GCC Countries

South Africa

Rest of MEA

Companies Profiled

23andMe, Inc.

Ancestry

CircleDNA

Eurofins Scientific

Family Tree DNA (Gene by Gene)

Laboratory Corporation of America Holdings

Living DNA Ltd.

Medichecks.com Ltd.

MyHeritage Ltd.

MyMedLab, Inc.

Quest Diagnostics Incorporated

Customization Scope

Available upon request

Pricing

Available upon request

Middle East & Africa Direct-to-Consumer Laboratory Testing Market – Segmentation

Test Type
  • Genetic Testing
    • Nutrigenetics Test
      • Weight Control
      • Lactose Intolerance
      • Others
    • Celiac Disease Test
    • Sports & Physical Activity Testing
    • Men's Health Tests
    • Women's Health Tests
    • Pregnancy & Prenatal Screening
    • General Health Testing
    • Others
  • Disease Risk Assessment Testing
    • Sexual Health Tests
      • HIV
      • Chlamydia
      • Others
    • Cancer Predisposition Tests
    • Others
  • CBC
  • Chronic Disease Testing
    • Diabetes Testing
    • Hypertension
    • Others
  • COVID-19 Testing
  • TSH Testing
  • Others
Sample Type
  • Blood
  • Saliva
  • Urine
  • Others
Provider
  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centers
Country/Sub-region
  • GCC Countries
  • South Africa
  • Rest of MEA
Middle East Africa Direct-to-Consumer Laboratory Testing Market Outlook, 2021-2031

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: MEA Direct-to-Consumer Laboratory Testing Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key Industrial Events (licensing partnerships/mergers & acquisitions)

    5.2. Disease Prevalence & Incidence Rate

    5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Sample Type, 2017–2031

        6.3.1. Blood

        6.3.2. Urine

        6.3.3. Saliva

        6.3.4. Others

    6.4. Market Attractiveness Analysis, by Sample Type

7. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Test Type, 2017–2031

        7.3.1. Genetic Testing

            7.3.1.1. Nutrigenetics Test

                7.3.1.1.1. Weight Control

                7.3.1.1.2. Lactose Intolerance

                7.3.1.1.3. Others

            7.3.1.2. Celiac Disease Test

            7.3.1.3. Sports & Physical Activity Testing

            7.3.1.4. Men's Health Tests

            7.3.1.5. Women's Health Tests

            7.3.1.6. Pregnancy & Prenatal Screening Test

            7.3.1.7. General Health Testing

            7.3.1.8. Others

        7.3.2. Disease Risk Assessment Testing

            7.3.2.1. Sexual Health Tests

                7.3.2.1.1. HIV

                7.3.2.1.2. Chlamydia

                7.3.2.1.3. Others

            7.3.2.2. Cancer Predisposition Tests

            7.3.2.3. Others

        7.3.3. CBC

        7.3.4. Chronic Disease Testing

            7.3.4.1. Diabetes Testing

            7.3.4.2. Hypertension

            7.3.4.3. Others

        7.3.5. COVID-19 Testing

        7.3.6. TSH Testing

        7.3.7. Others

    7.4. Market Attractiveness Analysis, by Test Type

8. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Provider

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Provider, 2017–2031

        8.3.1. Hospitals

        8.3.2. Clinics

        8.3.3. Specialty Labs

        8.3.4. Diagnostic Centers

    8.4. Market Attractiveness Analysis, by Provider

9. GCC Countries Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Sample Type, 2017–2031

        9.2.1. Blood

        9.2.2. Urine

        9.2.3. Saliva

        9.2.4. Others

    9.3. Market Value Forecast, by Test Type, 2017–2031

        9.3.1. Genetic Testing

            9.3.1.1. Nutrigenetics Test

                9.3.1.1.1. Weight Control

                9.3.1.1.2. Lactose Intolerance

                9.3.1.1.3. Others

            9.3.1.2. Celiac Disease Test

            9.3.1.3. Sports & Physical Activity Testing

            9.3.1.4. Men's Health Tests

            9.3.1.5. Women's Health Tests

            9.3.1.6. Pregnancy & Prenatal Screening Test

            9.3.1.7. General Health Testing

            9.3.1.8. Others

        9.3.2. Disease Risk Assessment Testing

            9.3.2.1. Sexual Health Tests

                9.3.2.1.1. HIV

                9.3.2.1.2. Chlamydia

                9.3.2.1.3. Others

            9.3.2.2. Cancer Predisposition Tests

            9.3.2.3. Others

        9.3.3. CBC

        9.3.4. Chronic Disease Testing

            9.3.4.1. Diabetes Testing

            9.3.4.2. Hypertension

            9.3.4.3. Others

        9.3.5. COVID-19 Testing

        9.3.6. TSH Testing

        9.3.7. Others

    9.4. Market Value Forecast, by Provider, 2017–2031

        9.4.1. Hospitals

        9.4.2. Clinics

        9.4.3. Specialty Labs

        9.4.4. Diagnostic Centers

10. South Africa Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Sample Type, 2017–2031

        10.2.1. Blood

        10.2.2. Urine

        10.2.3. Saliva

        10.2.4. Others

    10.3. Market Value Forecast, by Test Type, 2017–2031

        10.3.1. Genetic Testing

            10.3.1.1. Nutrigenetics Test

                10.3.1.1.1. Weight Control

                10.3.1.1.2. Lactose Intolerance

                10.3.1.1.3. Others

            10.3.1.2. Celiac Disease Test

            10.3.1.3. Sports & Physical Activity Testing

            10.3.1.4. Men's Health Tests

            10.3.1.5. Women's Health Tests

            10.3.1.6. Pregnancy & Prenatal Screening Test

            10.3.1.7. General Health Testing

            10.3.1.8. Others

        10.3.2. Disease Risk Assessment Testing

            10.3.2.1. Sexual Health Tests

                10.3.2.1.1. HIV

                10.3.2.1.2. Chlamydia

                10.3.2.1.3. Others

            10.3.2.2. Cancer Predisposition Tests

            10.3.2.3. Others

        10.3.3. CBC

        10.3.4. Chronic Disease Testing

            10.3.4.1. Diabetes Testing

            10.3.4.2. Hypertension

            10.3.4.3. Others

        10.3.5. COVID-110 Testing

        10.3.6. TSH Testing

        10.3.7. Others

    10.4. Market Value Forecast, by Provider, 2017–2031

        10.4.1. Hospitals

        10.4.2. Clinics

        10.4.3. Specialty Labs

        10.4.4. Diagnostic Centers

11. Rest of MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Sample Type, 2017–2031

        11.2.1. Blood

        11.2.2. Urine

        11.2.3. Saliva

        11.2.4. Others

    11.3. Market Value Forecast, by Test Type, 2017–2031

        11.3.1. Genetic Testing

            11.3.1.1. Nutrigenetics Test

                11.3.1.1.1. Weight Control

                11.3.1.1.2. Lactose Intolerance

                11.3.1.1.3. Others

            11.3.1.2. Celiac Disease Test

            11.3.1.3. Sports & Physical Activity Testing

            11.3.1.4. Men's Health Tests

            11.3.1.5. Women's Health Tests

            11.3.1.6. Pregnancy & Prenatal Screening Test

            11.3.1.7. General Health Testing

            11.3.1.8. Others

        11.3.2. Disease Risk Assessment Testing

            11.3.2.1. Sexual Health Tests

                11.3.2.1.1. HIV

                11.3.2.1.2. Chlamydia

                11.3.2.1.3. Others

            11.3.2.2. Cancer Predisposition Tests

            11.3.2.3. Others

        11.3.3. CBC

        11.3.4. Chronic Disease Testing

            11.3.4.1. Diabetes Testing

            11.3.4.2. Hypertension

            11.3.4.3. Others

        11.3.5. COVID-19 Testing

        11.3.6. TSH Testing

        11.3.7. Others

    11.4. Market Value Forecast, by Provider, 2017–2031

        11.4.1. Hospitals

        11.4.2. Clinics

        11.4.3. Specialty Labs

        11.4.4. Diagnostic Centers

12. Competition Landscape

    12.1. Market Player - Competition Matrix (by tier and size of companies)

    12.2. Company Profiles

        12.2.1. 23andMe, Inc.

            12.2.1.1. Company Description

            12.2.1.2. Business Overview

            12.2.1.3. Strategic Overview

            12.2.1.4. SWOT Analysis

        12.2.2. Ancestry

            12.2.2.1. Company Description

            12.2.2.2. Business Overview

            12.2.2.3. SWOT Analysis

        12.2.3. CircleDNA

            12.2.3.1. Company Description

            12.2.3.2. Business Overview

            12.2.3.3. SWOT Analysis

        12.2.4. Eurofins Scientific

            12.2.4.1. Company Description

            12.2.4.2. Business Overview

            12.2.4.3. Financial Overview

            12.2.4.4. SWOT Analysis

        12.2.5. Family Tree DNA (Gene by Gene)

            12.2.5.1. Company Description

            12.2.5.2. Business Overview

            12.2.5.3. SWOT Analysis

        12.2.6. Laboratory Corporation of America Holdings

            12.2.6.1. Company Description

            12.2.6.2. Business Overview

            12.2.6.3. Financial Overview

            12.2.6.4. Strategic Overview

            12.2.6.5. SWOT Analysis

        12.2.7. Living DNA Ltd.

            12.2.7.1. Company Description

            12.2.7.2. Business Overview

            12.2.7.3. SWOT Analysis

        12.2.8. Medichecks.com Ltd.

            12.2.8.1. Company Description

            12.2.8.2. Business Overview

            12.2.8.3. SWOT Analysis

        12.2.9. MyHeritage Ltd.

            12.2.9.1. Company Description

            12.2.9.2. Business Overview

            12.2.9.3. SWOT Analysis

        12.2.10. MyMedLab, Inc.

            12.2.10.1. Company Description

            12.2.10.2. Business Overview

            12.2.10.3. SWOT Analysis

        12.2.11. Quest Diagnostics Incorporated

            12.2.11.1. Company Description

            12.2.11.2. Business Overview

            12.2.11.3. Financial Overview

            12.2.11.4. Strategic Overview

            12.2.11.5. SWOT Analysis

List of Tables

Table 01: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 02: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 03: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 04: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 05: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 06: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 07: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 08: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 09: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 10: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 11: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 12: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 13: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 14: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 15: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 16: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 17: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 18: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 19: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 20: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 21: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 22: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 23: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 24: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 25: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 26: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 27: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 28: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 29: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 30: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 31: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 32: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

List of Figures

Figure 01: MEA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 02: MEA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 03: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017–2031

Figure 04: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 05: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 06: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 07: MEA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 08: MEA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 09: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Genetic Testing, 2017–2031

Figure 10: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Disease Risk Assessment Testing, 2017–2031

Figure 11: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by CBC, 2017–2031

Figure 12: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Chronic Disease Testing, 2017–2031

Figure 13: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by COVID-19 Testing, 2017–2031

Figure 14: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by TSH Testing, 2017–2031

Figure 15: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 16: MEA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 17: MEA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 18: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 19: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Clinics, 2017–2031

Figure 20: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Specialty Labs, 2017–2031

Figure 21: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Diagnostic Centers, 2017–2031

Figure 22: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 23: GCC Countries Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 24: GCC Countries Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 25: GCC Countries Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 26: GCC Countries Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 27: GCC Countries Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 28: GCC Countries Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 29: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 30: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 31: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 32: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 33: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 34: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 35: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

547

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved